Jeff Feller replied to the topic WHAT IS THE BEST OTC STOCK TO INVEST IN RIGHT NOW? in the forum Penny Stock Watchlist 1 year, 5 months ago
I still believe $NXEN has some potential right around the corner. They quietly hired a new IR / PR firm (announced in the last 10-Q), so I believe that’s a SIGN they have some things in the works. Why else would a company otherwise running low on funds hire an IR / PR firm?!
They have an Ivy League Medical School partner on the East Coast, but…Read More
OTC News Robot wrote a new post, $NXEN #OTCQB Nexien BioPharma, Inc. (NXEN: OTCQB) | Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services 1 year, 5 months ago
@feller, nice picks. Let’s post the websites below for reference.
PATH ONE Developing, licensing and commercializing cannabinoid based medications for specific medical conditions and disorders. Our drug development activities are undertaken in accordance with Food and Drug Administration (FDA) or comparable development pathways in other countries. Our intent is that any medications we develop will be physician prescribed.
$NXEN continues to be one I watch. It’s been accumulated over the past week or so — slowly moving up daily, for the most part. Last time it did this, it had it’s $0.03 to $0.445 run… This time, the accumulation/run would start from a higher price point. Same SUPER LOW FLOAT of around 11 Million.
Marijuana (311 Companies)
OTC News Robot wrote a new post, $NXEN #OTCQB Nexien BioPharma, Inc. (NXEN: OTCQB) | Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2 2 years, 1 month ago
- Load More